Ehong Gu

CFO

Equibles does not estimate personal net worth.

Get an email with a short summary when LianBio publishes a filing, an earnings call transcript or a press release.

About Ehong Gu

Ehong Gu is recorded as CFO at LianBio (LIANY) since December 19, 2023. LianBio reported in an 8-K filed December 20, 2023 that Ehong Gu was appointed Interim Chief Financial Officer, effective December 19, 2023. LianBio is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at LianBio includes Adam Stone (CEO and Board Member), Konstantin Poukalov (Board Member), Neil Kumar (Board Member) and 3 others.

“the Board appointed Ehong Gu as Interim Chief Financial Officer of the Company, in which role she will act as the Company's principal financial officer and principal accounting officer.”

LianBio Form 8-K, filed December 20, 2023 · Read the filing

Affiliation history

LianBio (LIANY)
CFO

SEC 8-K

Current
2023-12-19–present

Company network

LianBio

LIANY

Current role

Biotechnology · Healthcare

CFO

2023-12-19–present

Leadership on record at LianBio

Adam Stone CEO, Board Member
Konstantin Poukalov Board Member
Neil Kumar Board Member
Susan Silbermann Board Member
Tassos Gianakakos Board Member
Wei Wei Chen Board Member

Recent activity

Executive change Appointed: Interim Chief Financial Officer LianBio (LIANY)
2023-12-19